Company Overview of Mega Lifesciences Public Company Limited
Mega Lifesciences Public Company Limited manufactures and sells health food supplements, pharmaceutical and herbal products, and vitamins and minerals in Thailand. It provides various pharma products in the therapeutic areas of cardiology, dermatology, diabetes, gastroenterology, ortho, respiratory, and urology. The company also offers complementary medicines comprising children, diabetics, heart health, herbals, joint health, liver tonic, men’s and women’s health, skin care, slimming, sports supplements, and well being products; and OTC products for analgesics and NSAIDS, and gastrointestinal disorders. In addition, it provides software design and development services. Mega Lifesciences Pub...
Ample Tower Bangna
120, Moo 11
Founded in 1982
Key Executives for Mega Lifesciences Public Company Limited
Mega Lifesciences Public Company Limited does not have any Key Executives recorded.
Mega Lifesciences Public Company Limited Key Developments
Mega Lifesciences Public Company Limited Reports Consolidated and Company Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013
Nov 18 13
Mega Lifesciences Public Company Limited reported consolidated and company earnings results for the third quarter and nine months ended September 30, 2013. For the quarter on consolidated basis, net profit was THB 153.142 million against THB 128.143 million a year ago. EPS was THB 0.21 against THB 0.18 a year ago.
For the nine months on consolidated basis, net profit was THB 446.822 million against THB 431.694 million a year ago. EPS was THB 0.61 against THB 0.59 a year ago.
For the quarter on the company basis, net profit was THB 108.703 million against THB 36.598 million a year ago. EPS was THB 0.15 against THB 0.05 a year ago.
For the nine months on the company basis, net profit was THB 361.715 million against THB 166.952 million a year ago. EPS was THB 0.50 against THB 0.23 a year ago.
Mega Lifesciences Opens Second Thai Factory
Nov 8 13
Mega Lifesciences has outlined plans for ongoing expansion, with a second USD 15 million factory for production of gelatin capsules set to become operational in Thailand from January, and up to USD 19 million to be invested in construction of warehouse facilities in Myanmar. The Thai factory is the firm's second at the Bangpoo Industrial Estate in Samut Prakan province, and will boost Mega's annual soft gelatine capsule production capacity to 3.8 billion, from 2 billion now. In Myanmar, Mega states it will apply to the government during the first quarter of 2014 to build a warehouse in the city of Yangon. Construction would begin in 2015 if approved, with total cost expected in the range of USD 9.57 million to USD 19.14 million depending on land costs.
Mega Lifesciences Seeks Acquisitions
Oct 28 13
Mega Lifesciences Public Company Limited seeks acquisitions. Chief Executive Vivek Dhawan said the company will in next year's first quarter propose to the Myanmar government building the warehouse on 25 rai in Yangon. The actual cost will depend on the price of land. Construction is expected to start by 2015. The move is part of a bid to double overall company sales, both domestically and internationally, to $400 million over the next 3-5 years. The goal will be realized through organic growth and mergers and acquisitions, said Dhawan.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|